|
C17ORF85 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.572230E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.804200E-01 |
| Normal-vs-Stage2 |
5.856200E-01 |
| Normal-vs-Stage3 |
7.617900E-02 |
| Normal-vs-Stage4 |
9.864400E-03 |
| Stage1-vs-Stage2 |
6.163800E-01 |
| Stage1-vs-Stage3 |
6.542300E-02 |
| Stage1-vs-Stage4 |
5.304000E-03 |
| Stage2-vs-Stage3 |
4.444000E-01 |
| Stage2-vs-Stage4 |
1.299590E-01 |
| Stage3-vs-Stage4 |
3.130600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.140220E-01 |
| Normal-vs-AfricanAmerican |
4.957400E-01 |
| Normal-vs-Asian |
1.321420E-03 |
| Caucasian-vs-AfricanAmerican |
8.001000E-01 |
| Caucasian-vs-Asian |
1.015730E-02 |
| AfricanAmerican-vs-Asian |
1.756400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.538200E-02 |
| Normal-vs-Female |
7.809000E-01 |
| Male-vs-Female |
9.155300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.387390E-01 |
| Normal-vs-Age(41-60Yrs) |
8.594000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.254400E-02 |
| Normal-vs-Age(81-100Yrs) |
5.491200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.179200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.459800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.745400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.105700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.493200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.715200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.161300E-03 |
| Normal-vs-Grade 2 |
6.279200E-01 |
| Normal-vs-Grade 3 |
1.478250E-02 |
| Normal-vs-Grade 4 |
3.322300E-03 |
| Grade 1-vs-Grade 2 |
4.745900E-02 |
| Grade 1-vs-Grade 3 |
5.151000E-04 |
| Grade 1-vs-Grade 4 |
9.640600E-04 |
| Grade 2-vs-Grade 3 |
1.703750E-03 |
| Grade 2-vs-Grade 4 |
4.801100E-04 |
| Grade 3-vs-Grade 4 |
1.539830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.160960E-01 |
| Normal-vs-ccB subtype |
7.623900E-03 |
| ccA subtype-vs-ccB subtype |
3.898300000027E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.350800E-01 |
| Normal-vs-N1 |
8.559100E-03 |
| N0-vs-N1 |
1.079590E-01 |
|
|
